4//SEC Filing
Winton Matthew 4
Accession 0001209191-23-022465
CIK 0001693011other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:35 AM ET
Size
5.6 KB
Accession
0001209191-23-022465
Insider Transaction Report
Form 4
Transactions
- Award
Stock option (right to buy)
2023-04-03+250,000→ 250,000 totalExercise: $5.39Exp: 2033-04-02→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 3, 2023 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001971400
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 8:35 AM ET
- Size
- 5.6 KB